| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 7, Issue 10 1283-1290, Copyright © 1996 by American Association of Cancer Research
ARTICLES |
WA Bresnahan, I Boldogh, T Ma, T Albrecht and EA Thompson
Department of Microbiology, University of Texas Medical Branch, Galveston 77550, USA.
The experiments described in this report were undertaken to define the parameters that regulate cyclin E/cyclin-dependent kinase 2 (Cdk2) kinase activity in mitotically quiescent, serum-starved fibroblastic cells and in cells that had been stimulated to enter the cell cycle and progress through G1 into S phase. We have analyzed the expression of cyclin E and Cdk2, the extent to which these two proteins form complexes, and the enzymatic activity of cyclin E/cdk2 kinase. Particular attention was focused upon subcellular localization and the effect of compartmentalization on the association between cyclin E and Cdk2. In addition, we have examined the interaction of cyclin E/Cdk2 complexes with two well-characterized inhibitors of Cdk2 kinase activity, Cip1 and Kip1. This represents the first report in which all of these parameters have been measured simultaneously in a single, normal diploid cell line. In G0 cells, there is abundant cyclin E and Cdk2, yet there is little or no detectable Cdk2-dependent histone H1 kinase activity. After serum stimulation, there is a rapid increase in the amount of cyclin E that is bound to Cdk2, although there is no significant change in the abundance of either the cyclin or the Cdk. Immunocytochemical data indicate that cyclin E, Cip1, and Kip1 are located within the nuclei of cell in G0, but very little Cdk2 is observed within the nuclei of serum-starved cells. Cdk2 rapidly enters the nucleus upon serum stimulation. The abundance of the cyclin E/Cdk2 complex increases to the extent that the binding capacity of Cip1 is exceeded about 8-12 h after serum stimulation. The abundance of Kip1 decreases at the same time that the Cip1 threshold is exceeded, so that cyclin E/Kip1-containing complexes decrease by 90% within 8-12 h. Cyclin E/Cdk2 kinase activity begins to increase rapidly thereafter, reaching a maximum level about 16 h after serum stimulation. We have been unable to detect histone H1 kinase activity in complexes that contain cyclin E bound to Kip1 or Cip1. We conclude that compartmentalization is the predominant barrier to activation of cyclin E-dependent kinases in quiescent cells. Cip1 and Kip1 serve to prevent premature activation of cyclin E/Cdk2 complexes that form during G0 or early G1.
This article has been cited by other articles:
![]() |
W. Y. Tsang, L. Wang, Z. Chen, I. Sanchez, and B. D. Dynlacht SCAPER, a novel cyclin A interacting protein that regulates cell cycle progression J. Cell Biol., August 9, 2007; 178(4): 621 - 633. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. T. Taylor and W. A. Bresnahan Human Cytomegalovirus IE86 Attenuates Virus- and Tumor Necrosis Factor Alpha-Induced NF{kappa}B-Dependent Gene Expression. J. Virol., November 1, 2006; 80(21): 10763 - 10771. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. T. Taylor and W. A. Bresnahan Human Cytomegalovirus Immediate-Early 2 Protein IE86 Blocks Virus-Induced Chemokine Expression J. Virol., January 15, 2006; 80(2): 920 - 928. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Cantrell and W. A. Bresnahan Interaction between the Human Cytomegalovirus UL82 Gene Product (pp71) and hDaxx Regulates Immediate-Early Gene Expression and Viral Replication J. Virol., June 15, 2005; 79(12): 7792 - 7802. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Coulonval, L. Bockstaele, S. Paternot, and P. P. Roger Phosphorylations of Cyclin-dependent Kinase 2 Revisited Using Two-dimensional Gel Electrophoresis J. Biol. Chem., December 26, 2003; 278(52): 52052 - 52060. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. K. Hazra, T. Izumi, I. Boldogh, B. Imhoff, Y. W. Kow, P. Jaruga, M. Dizdaroglu, and S. Mitra From the Cover: Identification and characterization of a human DNA glycosylase for repair of modified bases in oxidatively damaged DNA PNAS, March 19, 2002; 99(6): 3523 - 3528. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. V. Ekholm, P. Zickert, S. I. Reed, and A. Zetterberg Accumulation of Cyclin E Is Not a Prerequisite for Passage through the Restriction Point Mol. Cell. Biol., May 1, 2001; 21(9): 3256 - 3265. [Abstract] [Full Text] |
||||
![]() |
V. Dulic, G.-E. Beney, G. Frebourg, L. F. Drullinger, and G. H. Stein Uncoupling between Phenotypic Senescence and Cell Cycle Arrest in Aging p21-Deficient Fibroblasts Mol. Cell. Biol., September 15, 2000; 20(18): 6741 - 6754. [Abstract] [Full Text] |
||||
![]() |
J.-L. Liu, Y. Ye, Z. Qian, Y. Qian, D. J. Templeton, L. F. Lee, and H.-J. Kung Functional Interactions between Herpesvirus Oncoprotein MEQ and Cell Cycle Regulator CDK2 J. Virol., May 1, 1999; 73(5): 4208 - 4219. [Abstract] [Full Text] |
||||
![]() |
G. H. Stein, L. F. Drullinger, A. Soulard, and V. Dulic Differential Roles for Cyclin-Dependent Kinase Inhibitors p21 and p16 in the Mechanisms of Senescence and Differentiation in Human Fibroblasts Mol. Cell. Biol., March 1, 1999; 19(3): 2109 - 2117. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Gomez Lahoz, N. J. Liegeois, P. Zhang, J. A. Engelman, J. Horner, A. Silverman, R. Burde, M. F. Roussel, C. J. Sherr, S. J. Elledge, et al. Cyclin D- and E-Dependent Kinases and the p57KIP2 Inhibitor: Cooperative Interactions In Vivo Mol. Cell. Biol., January 1, 1999; 19(1): 353 - 363. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. A. Bresnahan, T. Albrecht, and E. A. Thompson The Cyclin E Promoter Is Activated by Human Cytomegalovirus 86-kDa Immediate Early Protein J. Biol. Chem., August 21, 1998; 273(34): 22075 - 22082. [Abstract] [Full Text] [PDF] |
||||
![]() |
R J Sheaff, M Groudine, M Gordon, J M Roberts, and B E Clurman Cyclin E-CDK2 is a regulator of p27Kip1. Genes & Dev., June 1, 1997; 11(11): 1464 - 1478. [Abstract] [PDF] |
||||
![]() |
I Reynisdottir and J Massague The subcellular locations of p15(Ink4b) and p27(Kip1) coordinate their inhibitory interactions with cdk4 and cdk2. Genes & Dev., February 15, 1997; 11(4): 492 - 503. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |